Investor Overview

NASDAQ: XBIT0.004.15Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
DateTitle 
08/10/18XBiotech Highlights Quarterly DevelopmentsPrinter Friendly Version
07/10/18XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis SuppurativaPrinter Friendly Version
05/22/18XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic DermatitisPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »